Ingevity Corporation
NGVT
$71.64
-$0.39-0.54%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.11% | -0.21% | 12.36% | -16.50% | -29.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.11% | -0.21% | 12.36% | -16.50% | -29.16% |
| Cost of Revenue | 6.49% | -1.48% | 30.70% | -29.03% | -46.27% |
| Gross Profit | -17.33% | 1.75% | -5.39% | 13.74% | 33.92% |
| SG&A Expenses | 8.90% | 16.36% | 23.26% | -8.69% | -12.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.19% | 1.62% | 29.43% | -24.92% | -41.22% |
| Operating Income | -36.91% | -5.37% | -17.95% | 38.50% | 116.55% |
| Income Before Tax | -536.93% | 15.19% | 14.31% | 137.27% | 115.65% |
| Income Tax Expenses | -688.89% | 229.23% | 150.00% | 139.62% | 112.10% |
| Earnings from Continuing Operations | -502.04% | -14.11% | -0.23% | 136.61% | 116.78% |
| Earnings from Discontinued Operations | -93.33% | 101.75% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -609.64% | 140.58% | 48.36% | 136.61% | 114.21% |
| EBIT | -36.91% | -5.37% | -17.95% | 38.50% | 116.55% |
| EBITDA | -23.18% | -4.66% | -17.30% | 13.77% | 46.70% |
| EPS Basic | -615.49% | 140.62% | 48.51% | 136.49% | 114.25% |
| Normalized Basic EPS | -96.40% | -1.28% | -40.93% | 1,357.25% | 2,714.69% |
| EPS Diluted | -616.10% | 139.91% | 48.55% | 136.26% | 114.22% |
| Normalized Diluted EPS | -96.40% | -2.61% | -40.62% | 1,347.64% | 2,714.69% |
| Average Basic Shares Outstanding | -1.72% | -0.10% | 0.33% | 0.33% | 0.34% |
| Average Diluted Shares Outstanding | -1.72% | 1.27% | 0.33% | 1.10% | 0.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |